Literature DB >> 31116357

Association Between Parental Medical Claims for Opioid Prescriptions and Risk of Suicide Attempt by Their Children.

David A Brent1, Kwan Hur2, Robert D Gibbons2,3,4.   

Abstract

Importance: The rate of youth suicide has increased over the past 15 years in the United States as has the rate of death due to opioid overdose in adults of parental age. Objective: To explore the possible connection between parental use of prescription opioids and the increasing rate of youth suicide. Design, Setting, and Participants: A pharmacoepidemiologic study was conducted from January 1, 2010, to December 31, 2016, linking medical claims for parental opioid prescriptions with medical claims for suicide attempts by their children. The study used MarketScan medical claims data covering more than 150 million privately insured people in the United States. The study included 121 306 propensity score-matched 30- to 50-year-old parents who used opioids and parents who did not use opioids and their 10- to 19-year-old children (148 395 children of parents who did not use opioids and 184 142 children of parents who used opioids). Propensity score matching was used to identify relevant control families based on demographic features and concomitant use of psychotropic medication. Exposures: Opioid use in a parent was defined as having prescription fills covering more than 365 days of an opioid between 2010 and 2016. Main Outcomes and Measures: Suicide attempt rate in the children of parents who used opioids and those who did not use opioids.
Results: A total of 148 395 children (75 575 sons and 72 820 daughters; mean [SD] age, 11.5 [1.6] years at the start of follow-up) had parents who did not use opioids and 184 142 children (94 502 sons and 89 640 daughters; mean [SD] age, 11.8 [1.8] years at the start of follow-up) with parents who did use opioids. There were 100 899 children aged 10 to 14 years and 47 496 children aged 15 to 19 years with parents who did not use opioids and 96 975 children aged 10 to 14 years and 87 163 children aged 15 to 19 years with parents who did use opioids. Of the children with parents who did not use opioids, 212 (0.14%) attempted suicide; of the children with parents who did use opioids, 678 (0.37%) attempted suicide. Parental use of opioids was associated with a doubling of the risk of a suicide attempt by their offspring (odds ratio [OR], 1.99; 95% CI, 1.71-2.33). The association remained significant after adjusting for child age and sex (OR, 1.85; 95% CI, 1.58-2.17), addition of child and parental depression and diagnoses of substance use disorder (OR, 1.46; 95% CI, 1.24-1.72), and addition of parental history of suicide attempt (OR, 1.45; 95% CI, 1.23-1.71). Geographical variation in opioid use did not change the association (OR, 2.00; 95% CI, 1.71-2.34). Conclusions and Relevance: Children of parents who use prescription opioids are at increased risk for suicide attempts, which could be a contributing factor to the time trend in adolescent suicidality. The care of families with a parent who uses opioids should include mental health screening of their children.

Entities:  

Year:  2019        PMID: 31116357      PMCID: PMC6537764          DOI: 10.1001/jamapsychiatry.2019.0940

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  33 in total

1.  Suicidal thoughts and attempts among u.s. High school students: trends and associated health-risk behaviors, 1991-2011.

Authors:  Richard Lowry; Alexander E Crosby; Nancy D Brener; Laura Kann
Journal:  J Adolesc Health       Date:  2013-09-11       Impact factor: 5.012

2.  Familial pathways to early-onset suicide attempt: a 5.6-year prospective study.

Authors:  David A Brent; Nadine M Melhem; Maria Oquendo; Ainsley Burke; Boris Birmaher; Barbara Stanley; Candice Biernesser; John Keilp; David Kolko; Steve Ellis; Giovanna Porta; Jamie Zelazny; Satish Iyengar; J John Mann
Journal:  JAMA Psychiatry       Date:  2015-02       Impact factor: 21.596

3.  Parental psychopathology and offspring suicidality in Mexico.

Authors:  Guilherme Borges; Rebeca Borges; Maria-Elena Medina Mora; Corina Benjet; Matthew K Nock
Journal:  Arch Suicide Res       Date:  2013

4.  Persisting decline in depression treatment after FDA warnings.

Authors:  Anne M Libby; Heather D Orton; Robert J Valuck
Journal:  Arch Gen Psychiatry       Date:  2009-06

5.  Drug Overdose Deaths Among Adolescents Aged 15-19 in the United States: 1999-2015.

Authors:  Sally C Curtin; Betzaida Tejada-Vera; Margaret Warmer
Journal:  NCHS Data Brief       Date:  2017-08

6.  Psychiatric diagnosis in child and adolescent suicide.

Authors:  D Shaffer; M S Gould; P Fisher; P Trautman; D Moreau; M Kleinman; M Flory
Journal:  Arch Gen Psychiatry       Date:  1996-04

7.  Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.

Authors:  Laurence Y Katz; Anita L Kozyrskyj; Heather J Prior; Murray W Enns; Brian J Cox; Jitender Sareen
Journal:  CMAJ       Date:  2008-04-08       Impact factor: 8.262

8.  Parental psychopathology and the risk of suicidal behavior in their offspring: results from the World Mental Health surveys.

Authors:  O Gureje; B Oladeji; I Hwang; W T Chiu; R C Kessler; N A Sampson; J Alonso; L H Andrade; A Beautrais; G Borges; E Bromet; R Bruffaerts; G de Girolamo; R de Graaf; G Gal; Y He; C Hu; N Iwata; E G Karam; V Kovess-Masféty; H Matschinger; M V Moldovan; J Posada-Villa; R Sagar; P Scocco; S Seedat; T Tomov; M K Nock
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

9.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies.

Authors:  Peter C Austin
Journal:  Multivariate Behav Res       Date:  2011-06-08       Impact factor: 5.923

Review 10.  Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.

Authors:  Marc Stone; Thomas Laughren; M Lisa Jones; Mark Levenson; P Chris Holland; Alice Hughes; Tarek A Hammad; Robert Temple; George Rochester
Journal:  BMJ       Date:  2009-08-11
View more
  8 in total

1.  Trends in the Incidence and Lethality of Suicidal Acts in the United States, 2006 to 2015.

Authors:  Jing Wang; Steven A Sumner; Thomas R Simon; Alex E Crosby; Francis B Annor; Elizabeth Gaylor; Likang Xu; Kristin M Holland
Journal:  JAMA Psychiatry       Date:  2020-07-01       Impact factor: 21.596

2.  Concomitant opioid and benzodiazepine use and risk of suicide attempt and intentional self-harm: Pharmacoepidemiologic study.

Authors:  Robert D Gibbons; Kwan Hur; Patrick D Quinn
Journal:  Drug Alcohol Depend       Date:  2021-09-20       Impact factor: 4.492

3.  A national profile of substance use disorder among Medicaid enrollees on the autism spectrum or with intellectual disability.

Authors:  Anne M Roux; Sha Tao; Steven Marcus; Viktor Lushin; Lindsay L Shea
Journal:  Disabil Health J       Date:  2022-03-07       Impact factor: 4.615

4.  Assessment of Prescription Opioid Medical Use and Misuse Among Parents and Their Adolescent Offspring in the US.

Authors:  Pamela C Griesler; Mei-Chen Hu; Melanie M Wall; Denise B Kandel
Journal:  JAMA Netw Open       Date:  2021-01-04

5.  A trend analysis of the prevalence of opioid misuse, social support, and suicide attempt among American Indian/Alaska native high school students in New Mexico: 2009-2019 Youth Risk Resiliency Survey (YRRS).

Authors:  Daniel Opoku Agyemang; Erin Fanning Madden; Kevin English; Kamilla L Venner; Handy Rod; Tejinder Pal Singh; Fares Qeadan
Journal:  BMC Public Health       Date:  2022-02-21       Impact factor: 3.295

6.  Evaluating the Effectiveness of a Web-Based Program (POP4Teens) to Prevent Prescription Opioid Misuse Among Adolescents: Randomized Controlled Trial.

Authors:  Lisa A Marsch; Sarah K Moore; Michael Grabinski; Sarah Y Bessen; Jacob Borodovsky; Emily Scherer
Journal:  JMIR Public Health Surveill       Date:  2021-02-25

7.  Dynamics of Parental Opioid Use and Children's Health and Well-Being: An Integrative Systems Mapping Approach.

Authors:  Jessica C Smith; Leigh Alderman; Brandon K Attell; Wendy Avila Rodriguez; Jana Covington; Brigitte Manteuffel; Ann M DiGirolamo; Susan M Snyder; Karen Minyard
Journal:  Front Psychol       Date:  2021-06-29

Review 8.  Illuminating the Black Box: Interpreting Deep Neural Network Models for Psychiatric Research.

Authors:  Yi-Han Sheu
Journal:  Front Psychiatry       Date:  2020-10-29       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.